- 专利标题: SOLID FORMS OF (3R)-N-[2-CYANO-4-FLUORO-3-(3-METHYL-4-OXO-QUINAZOLIN-6-YL)OXY-PHENYL]-3-FLUORO-PYRROLIDINE-1-SULFONAMIDE
-
申请号: US18533710申请日: 2023-12-08
-
公开(公告)号: US20240199585A1公开(公告)日: 2024-06-20
- 发明人: Bengt ÅSLUND , Manuel KONRATH , Ulf Goeran LARSSON , Johan Salman MALMBERG , Alexander Bogdan Emil MINIDIS , Isabelle Georgette Huguette MODOLO-CHELLAT
- 申请人: Hoffmann-La Roche Inc.
- 申请人地址: US NJ Little Falls
- 专利权人: Hoffmann-La Roche Inc.
- 当前专利权人: Hoffmann-La Roche Inc.
- 当前专利权人地址: US NJ Little Falls
- 优先权: EP 178622.3 2021.06.09
- 主分类号: C07D403/12
- IPC分类号: C07D403/12 ; A61K9/00 ; A61K9/02 ; A61K9/20 ; A61K9/48 ; A61K31/517 ; A61K47/10 ; A61K47/12 ; A61K47/26 ; A61K47/32 ; A61K47/38
摘要:
The present invention provides solid forms of (3R)-N-[2-cyano-4-fluoro-3-(3-methyl-4-oxo-quinazolin-6-yl)oxy-phenyl]-3-fluoro-pyrrolidine-1-sulfonamide and solvates thereof, as well as therapeutic uses and processes to manufacture the new solid forms.
信息查询